The authors revealed that overexpression of lncRNA MAGI2-AS3, which acts as a cis-regulatory element to downregulate DNA methylation in the promoter region of MAGI2, inhibits proliferation and migration of BC cells and may be associated with a better prognosis of BC patient survival. The gene discussed is MAGI2; the disease is breast cancer.